US/UK/Canada

Share

Pick a time period -
Tags ( Active)

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2024 Annual General Meeting

October 30, 2023 – InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2024 Annual General Meeting. The responsibility of the Nomination Committee is to present to the 2024 Annual General Meeting proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.The Nomination Committee for the 2024 Annual General Meeting of InDex Pharmaceuticals Holding AB (publ) consists of: · Karl Tobieson,

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2023 Annual General Meeting

October 26, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2023 Annual General Meeting. The responsibility of the Nomination Committee is to present to the 2023 Annual General Meeting proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.The Nomination Committee for the 2023 Annual General Meeting of InDex Pharmaceuticals Holding AB (publ) consists of: · Karl Tobieson,

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2022 Annual General Meeting

November 10, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2022 Annual General Meeting. The responsibility of the Nomination Committee is to present to the 2022 Annual General Meeting proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.The Nomination Committee for the 2022 Annual General Meeting of InDex Pharmaceuticals Holding AB (publ) consists of: · Karl Tobieson,

InDex Pharmaceuticals Holding AB (publ) announces changes in the Nomination Committee for the 2021 Annual General Meeting

March 15, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced changes in the composition of the Nomination Committee for the 2021 Annual General Meeting due to changes in the ownership structure of the company.Changes in the ownership structure of InDex Pharmaceuticals Holding AB (publ) in connection with the rights issue in February 2021 has led to changes in the composition of the Nomination Committee for the 2021 Annual General Meeting. Following the changes, the Nomination Committee for the 2021 Annual General Meeting of InDex Pharmaceuticals Holding AB (publ) consists of:

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2021 Annual General Meeting

December 3, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2021 Annual General Meeting. The responsibility of the Nomination Committee is to present to the 2021 Annual General Meeting proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.The Nomination Committee for the 2021 Annual General Meeting of InDex Pharmaceuticals Holding AB (publ) consists of: · Andreas Pennervall,

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2020 Annual General Meeting

November 1, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2020 Annual General Meeting. The responsibility of the Nomination Committee is to present to the 2020 Annual General Meeting proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.The Nomination Committee for the 2020 Annual General Meeting of InDex Pharmaceuticals Holding AB (publ) consists of: · Filip Pettersson,

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2019 Annual General Meeting

November 6, 2018 – InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2019 Annual General Meeting, which will be held on Monday May 6, 2019. The responsibility of the Nomination Committee is to present to the 2019 Annual General Meeting  proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.The Nomination Committee for the 2019 Annual General Meeting of InDex Pharmaceuticals Holding AB (

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee and financial reporting dates for 2018

November 16, 2017 – InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2018 Annual General Meeting, which will be held on Thursday May 24, 2018. The responsibility of the Nomination Committee is to present to the 2018 Annual General Meeting  proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditor.The Nomination Committee for the 2018 Annual General Meeting of InDex Pharmaceuticals Holding AB

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe